Karmali, R., Chukkapalli, V., Gordon, L. I., Borgia, J. A., Ugolkov, A., Mazar, A. P., & Giles, F. J. (2017). GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents. Oncotarget.

Karmali, Reem, Vineela Chukkapalli, Leo I. Gordon, Jeffrey A. Borgia, Andrey Ugolkov, Andrew P. Mazar, and Francis J. Giles. "GSK-3β Inhibitor, 9-ING-41, Reduces Cell Viability and Halts Proliferation of B-cell Lymphoma Cell Lines As a Single Agent and in Combination With Novel Agents." Oncotarget 2017.

Karmali, Reem, et al. "GSK-3β Inhibitor, 9-ING-41, Reduces Cell Viability and Halts Proliferation of B-cell Lymphoma Cell Lines As a Single Agent and in Combination With Novel Agents." Oncotarget 2017.